193 related articles for article (PubMed ID: 22294052)
1. Central nervous system lymphoma occurring in a patient with neurofibromatosis type 1 (von Recklinghausen disease).
Eoli M; Bianchessi D; Di Stefano AL; Prodi E; Anghileri E; Finocchiaro G
Neurol Sci; 2012 Dec; 33(6):1429-33. PubMed ID: 22294052
[TBL] [Abstract][Full Text] [Related]
2. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic].
Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J
Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 1 and sporadic optic gliomas.
Singhal S; Birch JM; Kerr B; Lashford L; Evans DG
Arch Dis Child; 2002 Jul; 87(1):65-70. PubMed ID: 12089128
[TBL] [Abstract][Full Text] [Related]
4. Oncologic manifestations in children with neurofibromatosis type 1 in Turkey.
İncecik F; Altunbaşak Ş; Hergüner MÖ; Bayram İ; Küpeli S; Demirbilek H
Turk J Pediatr; 2013; 55(3):266-70. PubMed ID: 24217072
[TBL] [Abstract][Full Text] [Related]
5. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
[TBL] [Abstract][Full Text] [Related]
6. Unilateral gingival enlargement in patient with neurofibromatosis type I.
Asgary S; Aminzadeh N
N Y State Dent J; 2012 Nov; 78(6):50-3. PubMed ID: 23488326
[TBL] [Abstract][Full Text] [Related]
7. An update on the central nervous system manifestations of neurofibromatosis type 1.
Nix JS; Blakeley J; Rodriguez FJ
Acta Neuropathol; 2020 Apr; 139(4):625-641. PubMed ID: 30963251
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
[TBL] [Abstract][Full Text] [Related]
9. [Neurofibromatosis type I (NF1): peculiarities and complications].
Pascual-Castroviejo I
Rev Neurol; 1996 Sep; 24(133):1051-5. PubMed ID: 8755343
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis type 1 and malignancy in childhood.
Varan A; Şen H; Aydın B; Yalçın B; Kutluk T; Akyüz C
Clin Genet; 2016 Mar; 89(3):341-5. PubMed ID: 26073032
[TBL] [Abstract][Full Text] [Related]
11. Lymphoproliferative malignancies in patients with neurofibromatosis 1.
Bergqvist C; Hemery F; Jannic A; Ferkal S; Wolkenstein P
Orphanet J Rare Dis; 2021 May; 16(1):230. PubMed ID: 34011343
[TBL] [Abstract][Full Text] [Related]
12. Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas.
Johnson KJ; Fisher MJ; Listernick RL; North KN; Schorry EK; Viskochil D; Weinstein M; Rubin JB; Gutmann DH
Fam Cancer; 2012 Dec; 11(4):653-6. PubMed ID: 22829012
[TBL] [Abstract][Full Text] [Related]
13. Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study.
Peltonen S; Kallionpää RA; Rantanen M; Uusitalo E; Lähteenmäki PM; Pöyhönen M; Pitkäniemi J; Peltonen J
Int J Cancer; 2019 Dec; 145(11):2926-2932. PubMed ID: 30724342
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings.
Menor F; Marti-Bonmati L; Arana E; Poyatos C; Cortina H
Eur J Radiol; 1998 Jan; 26(2):121-31. PubMed ID: 9518221
[TBL] [Abstract][Full Text] [Related]
15. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
16. Gliomas in patients with neurofibromatosis type 1.
Albers AC; Gutmann DH
Expert Rev Neurother; 2009 Apr; 9(4):535-9. PubMed ID: 19344304
[TBL] [Abstract][Full Text] [Related]
17. Iris melanoma in a patient with neurofibromatosis.
Honavar SG; Singh AD; Shields CL; Shields JA; Eagle RC
Surv Ophthalmol; 2000; 45(3):231-6. PubMed ID: 11094247
[TBL] [Abstract][Full Text] [Related]
18. Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1.
Cecen E; Ince D; Uysal KM; Ozer E; Cetingoz R; Ozguven AA; Cakmakci H; Sarialioglu F; Olgun N
Childs Nerv Syst; 2011 Nov; 27(11):1885-93. PubMed ID: 21442270
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of multiple Cerebral Cavernous Malformations in a patient with Neurofibromatosis type 1.
Rerat K; Parker F; Nasser G; Vidaud D; Riant F; Tournier-Lasserve E; Denier C
J Neurol Sci; 2015 Mar; 350(1-2):98-100. PubMed ID: 25702150
[TBL] [Abstract][Full Text] [Related]
20. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
